Technologies Available for Licensing
ATTENUATED JAPANESE ENCEPHALITIS VIRUS ADAPTED TO VERO CELLS AND A JAPANESE ENCEPHALITIS VACCINE
Novel burst-free, sustained release biocompatible and biodegrable microcapsules which can be programmed to release their active core for variable durations ranging from 1-100 days in an aqueous physiological environment. The microcapsules are comprised of a core of polypeptide or other biologically active agent encapsulated in a matrix of poly(lactide/glycolide) copolymer, which may contain a pharmaceutically-acceptable adjuvant, as a blend of upcapped free carboxyl end group and end-capped forms ranging in ratios from 100/0 to 1/99.
More Detail:Visit USPTO.GOV
Inventor(s):KIM, H.; YOO, W.; KIM, S.; LEE, S.; MOON, S.; HONG, S.; SHIN, Y.; CHUNG, Y.; ECKELS, K.; INNIS, B.; PUNIAK, J.; BINN, L.; SRIVASTAVA, A.; DUBOIS, D.